A man born with a congenital heart murmur developed systemic arterial hypertension as an adult. At age 50, he went to the hospital because of dyspnea. He also had a pulmonic valve ejection click and murmur of pulmonic stenosis. When at the hospital, his echocardiogram showed hypertrophy of both ventricles as well as an enlarged right atrium.

The first report to address long-term outcomes for patients with severe native mitral regurgitation (MR) who are treated with transcatheter mitral valve replacement has found that post-procedural reductions in MR held up over time, with no significant recurrence upon two-year follow-up.

WESTLAKE, Texas, Aug. 17, 2017 — HeartSciences today announced the European launch of MyoVista® high sensitivity electrocardiograph (hsECG™) Testing Device, developed in response to the global unmet need for effective, low-cost, front-line screening of cardiac disease in both symptomatic and asymptomatic patients.

AUM Cardiovascular has received clearance from the U.S. Food and Drug Administration (FDA) for its acoustic and ECG device to detect heart murmurs.

InTouch Health, the leading enterprise telehealth platform, announced today a partnership agreement with Cardiovascular Institute of the South (CIS) to provide remote medical services geared towards emergent and general cardiology expertise in acute settings, adding a fourth service line to the company's physician capacity management offering. CIS will increase breadth and depth of adoption of InTouch Health's services, and extend its cardiology expertise to InTouch Health in two critical ways: (1) addition of cardiologists to InTouch Health's physician capacity management offering, and (2) collaboration on development of workflow solutions to drive best practices and allow for standardized quality of care in telecardiology settings.

New research from Monaco suggests that breast implants can impede electrocardiogram (ECG) recordings, leading to false readings and potentially incorrect heart attack diagnoses.

A new mitral regurgitation (MR) therapy designed to treat patients with structural heart disease was shown to be a safer treatment option than other transcatheter mitral valve replacement (TMVR) in a presentation at this year’s Transcatheter Valve Therapies (TVT) conference in Chicago.

Premium cardiac and vascular imaging rises to a new standard as Hitachi Healthcare Americas introduces the new premium 2D and 3D cardiovascular ultrasound system, the LISENDO 880, at the American Society of Echocardiography 2017 in Baltimore, Maryland on June 3rd, 2017.